Breaking: Trump to roll out plan for lowering drug prices

Pfizer strikes deal with administration to reduce some prices, avoid tariffs for three years.

Log In    Subscribe BREAKING NEWS   Trump to roll out plan aimed at lowering prescription drug prices By Matthew Herper, Daniel Payne, and Elaine Chen Alex Wong/Getty Images President Trump plans to announce lower prices on drugs from Pfizer and a new direct-to-consumer platform for prescription drugs on Tuesday.   The impending announcement comes the day after a Trump-imposed deadline for pharma companies to take action to lower drug prices and as the industry faces multiple challenges in Washington. READ MORE Sign up for D.C. Diagnosis Washington never stops. Cut through the noise with our essential updates on health care politics and policy. Learn more. In Case You Missed It 1   Days before Trump deadline to lower prices, companies push a flurry of initiatives. Will it be enough? By Elaine Chen and Daniel Payne 2   Why direct-to-consumer sales are unlikely to significantly lower drug costs By Elaine Chen 3   U.K. debate over investment in pharma grows louder as Trump, an interested party, pays a visit By Andrew Joseph 4   Lilly executives: How the FDA's new PreCheck program can unleash the future of U.S. medicine manufacturing By Jeffrey Francer and Victor Cruz Don't miss out on another STAT investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us